Searchable abstracts of presentations at key conferences in endocrinology

ea0009s2biog | Clinical Endocrinology Trust Visiting Professor Lecture | BES2005

Clinical Endocrinology Trust Visiting Professor Lecture

Jens Sandahl Christiansen

Jens Sandahl Christiansen, Medical Department M, Aarhus University Hospital, Aarhus, Denmark AbstractJens Sandahl Christiansen, MD, is professor of medicine and consultant endocrinologist at Aarhus University Hospital, Kommunehospitalet, Aarhus, Denmark. He graduated from Copenhagen University Medical School, and has been trained in diabetes and endocrinology in Copenhagen and Aarhus.Dr. Chr...

ea0032p497 | Endocrine disruptors | ECE2013

Reproductive aging in rats is altered by developmental exposure to mixtures of endocrine disrupters

Boberg Julie , Isling Louise Krag , Christiansen Sofie , Axelstad Marta , Jacobsen Pernille , Hass Ulla

Long-lasting and/or delayed reproductive effects of developmental exposure to mixtures of environmental chemicals were investigated in rats. Wistar rats were exposed to mixtures of estrogenic or anti-androgenic endocrine disrupters in pregnancy and lactation, and effects in offspring at 12–18 months of age were studied. The mixture included 13 estrogenic and anti-androgenic chemicals, including phthalates, pesticides, u.v.-filters, bisphenol A, butylparaben and paracetamo...

ea0009s2 | Clinical Endocrinology Trust Visiting Professor Lecture | BES2005

Growth hormone - not only for growth, but for life?

Christiansen J

Growth hormone (GH) is secreted throughout life - albeit in diminishing quantities with age. Its many different physiological actions have been known since the classical work of Maurice Raben in the late fifties. However, due to lack of the hormone, replacement therapy was for many years restricted to the pediatric treatment of growth disorder, and its place in medicine became tightly connected with growth, and growth alone. Since the mid eighties natural sequence GH have been...

ea0037ew1.5 | Practical publishing advice | ECE2015

Open access

Christiansen Jens Sandahl

Open access publishing provides authors with the highest possible visibility for their work, as articles are made freely available online to everyone. Many funding bodies and institutions around the world are adopting policies, which require their researchers to publish their work open access. Do you know how open access policies affect you, and how to comply? This talk will clarify what open access publishing means, including the difference between green and gold open access ...

ea0026pl3 | Targets for the management of diabetes in 2011 | ECE2011

Targets for the managent of diabetes 2011

Christiansen Jens Sandahl

The Management of both type 1 diabetes (T1DM) and type 2 diabetes (T2DM) involves careful monitoring and treatment of hypertension, hyperlipidaemia and hyperglycaemia. Aggressive treatment of high blood pressure and high cholesterol has been proven effective in reducing mortality in both T1DM and T2DM. Various guidelines advocate certain values for blood pressure and for cholesterol to be aimed for. These cut-off values have been pushed downwards constantly during the last 3 d...

ea0011s91 | Contrasting practices in European endocrinology | ECE2006

Contrasting expenditure on expensive endocrine therapies – e.g. growth hormone

Sandahl Christiansen Jens

The clinical syndrome associated with profound growth hormone deficiency (GHD) in adults has now been established and recognised for more than ten years. The multiple physiological and metabolic actions of growth hormone (GH) has been shown in a logical way to translate into recognisable symptoms and signs in individuals lacking the hormone. Normalization of abnormal physiological and metabolic parameters secondary to GH-replacement therapy has been demonstrated beyond reasona...

ea0029p464 | Clinical case reports - Thyroid/Others | ICEECE2012

Severe fetal and neonatal hyperthyroidism following radioiodine therapy in a woman with Graves’ disease

Bjorgaas M. , Farstad H. , Christiansen S. , Blaas H.

Introduction: Radioiodine (RAI)-therapy for Graves’ disease (GD) is often followed by worsening autoimmunity, and the increase in TRAb may persist for several years. In pregnant women TRAb pass the placenta and may stimulate the fetal TSH receptor with a risk of fetal and neonatal hyperthyroidism.Case report: A 21-year old woman with GD was treated with RAI, and subsequently was euthyroid with L-T4-replacement. Before RAI-therapy, TRAb was 8 U/l (re...

ea0014p616 | (1) | ECE2007

Protein metabolism in a model of premature ovarian failure, Turner syndrome, and the impact of hormone replacement therapy

Gravholt Claus H , Riis Anne-Lene , Christiansen Jens Sandahl

Background: Several studies have documented an altered body composition in Turner syndrome (TS), a model of premature ovarian failure. Body fat is increased and muscle mass is decreased. The ovarian failure necessitates substitution with female hormone replacement therapy (HRT) for a number of years, and HRT induces favourable changes in body composition with a decrease in body fat and an increase in fat free mass. It is unknown how HRT affects protein metabolism.<p class=...

ea0014p475 | (1) | ECE2007

Six months physiological DHEA substitution in female adrenal failure: impact on quality of life and sexual parameters.

Christiansen Jens J , Mehlsen Mimi , Geraldi Anna Maria , Gravholt Claus , Jørgensen Jens O , Christiansen Jens S

Female adrenal failure involves impaired DHEA secretion and very low circulating androgens. To address the impact of a daily physiological substitution dose of capsule DHEA 50 mg on quality of life and sexual parameters, we performed a 6 month trial in a randomised, crossover and placebo controlled design. The trial was approved by the local ethical committee and conducted according to GCP guidelines. Ten patients were enrolled. Seven patients reported seborrhoic side effects ...